IL145797A0 - Production of attenuated negative stranded rna virus vaccines from cloned nucleotide sequences - Google Patents

Production of attenuated negative stranded rna virus vaccines from cloned nucleotide sequences

Info

Publication number
IL145797A0
IL145797A0 IL14579700A IL14579700A IL145797A0 IL 145797 A0 IL145797 A0 IL 145797A0 IL 14579700 A IL14579700 A IL 14579700A IL 14579700 A IL14579700 A IL 14579700A IL 145797 A0 IL145797 A0 IL 145797A0
Authority
IL
Israel
Prior art keywords
production
nucleotide sequences
stranded rna
rna virus
virus vaccines
Prior art date
Application number
IL14579700A
Original Assignee
Government Of The Us Dept Of H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Government Of The Us Dept Of H filed Critical Government Of The Us Dept Of H
Publication of IL145797A0 publication Critical patent/IL145797A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18611—Respirovirus, e.g. Bovine, human parainfluenza 1,3
    • C12N2760/18622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18611—Respirovirus, e.g. Bovine, human parainfluenza 1,3
    • C12N2760/18641—Use of virus, viral particle or viral elements as a vector
    • C12N2760/18643—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18611—Respirovirus, e.g. Bovine, human parainfluenza 1,3
    • C12N2760/18661—Methods of inactivation or attenuation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18811—Sendai virus
    • C12N2760/18822—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL14579700A 1999-04-13 2000-04-12 Production of attenuated negative stranded rna virus vaccines from cloned nucleotide sequences IL145797A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12900699P 1999-04-13 1999-04-13
PCT/US2000/009695 WO2000061737A2 (en) 1999-04-13 2000-04-12 Production of attenuated negative stranded rna virus vaccines

Publications (1)

Publication Number Publication Date
IL145797A0 true IL145797A0 (en) 2002-07-25

Family

ID=22438049

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14579700A IL145797A0 (en) 1999-04-13 2000-04-12 Production of attenuated negative stranded rna virus vaccines from cloned nucleotide sequences

Country Status (10)

Country Link
EP (1) EP1171623A2 (en)
JP (1) JP4646410B2 (en)
KR (1) KR100760328B1 (en)
CN (1) CN1347458A (en)
AU (2) AU781238B2 (en)
BR (1) BR0011159A (en)
CA (1) CA2369817A1 (en)
IL (1) IL145797A0 (en)
MX (1) MXPA01010392A (en)
WO (1) WO2000061737A2 (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7485440B2 (en) 1995-09-27 2009-02-03 The United States Of America As Represented By The Department Of Health And Human Services Production of attenuated respiratory syncytial virus vaccines involving modification of M2 ORF2
US6699476B1 (en) 1996-07-15 2004-03-02 Peter L. Collins Production of recombinant respiratory syncytial viruses expressing immune modulatory molecules
BR9710363A (en) 1996-07-15 2000-01-11 Us Gov Health & Human Serv "Isolated infectious recombinant respiratory syncytial virus, particulate, processes to stimulate an individual's immune system to induce protection against respiratory syncytial virus and to produce a particle of recombinant respiratory syncytial virus, vaccine to induce protection against recombinant respiratory syncytial virus. composition and collection of recombinant respiratory syncytial virus "
US7192593B2 (en) 1997-05-23 2007-03-20 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Use of recombinant parainfluenza viruses (PIVs) as vectors to protect against infection and disease caused by PIV and other human pathogens
US7632508B2 (en) 1997-05-23 2009-12-15 The United States Of America Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines
US7951383B2 (en) 1997-05-23 2011-05-31 The United States Of America As Represented By The Department Of Health And Human Services Attenuated parainfluenza virus (PIV) vaccines
US7201907B1 (en) 1997-05-23 2007-04-10 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Attenuated human-bovine chimeric parainfluenza virus(PIV) vaccines
US20030082209A1 (en) 2000-07-05 2003-05-01 Skiadopoulos Mario H. Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines
US7662397B2 (en) 1997-07-15 2010-02-16 The United States Of America As Represented By The Department Of Health And Human Services Respiratory syncytial virus vaccines expressing protective antigens from promoter-proximal genes
US20040005542A1 (en) 2001-06-22 2004-01-08 Krempl Christine D Respiratory syncytial virus vaccines expressing protective antigens from promotor- proximal genes
JP2003530073A (en) 1999-07-09 2003-10-14 アメリカ合衆国 Production of an attenuated human-bovine chimeric respiratory syncytial virus vaccine
ATE307606T1 (en) * 2001-10-04 2005-11-15 Ct Voor Onderzoek In Diergenee ATTENUATED MUTANT STRAIN OF NEWCASTLE DISEASE VIRUS FOR IN OVO VACCINATION AND USE THEREOF
US7820181B2 (en) 2002-09-18 2010-10-26 The United States Of America As Represented By The Department Of Health And Human Services Recovery of recombinant human parainfluenza virus type 2 (HPIV2) from cDNA and use of recombinant HPIV2 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens
US7704491B2 (en) 2003-02-28 2010-04-27 The United States Of America As Represented By The Department Of Health And Human Services Recombinant human metapneumovirus and its use
BRPI0411247A (en) 2003-06-09 2006-07-25 Wyeth Corp improved process for recovering non-segmented negative filament rna viruses from cdna
KR20090114431A (en) * 2007-02-07 2009-11-03 디나벡크 가부시키가이샤 Attenuated minus-stranded RNA virus
JP2013531496A (en) * 2010-06-06 2013-08-08 モウント シナイ スクール オフ メディシネ Recombinant RNA virus and use thereof
CN103525777B (en) * 2013-07-01 2016-05-18 中国农业科学院兰州兽医研究所 Attenuated vaccine strain of VII type NDV L gene mutation and preparation method thereof
AU2018298499B2 (en) * 2017-07-03 2024-07-18 Bharat Biotech International Limited A synthetic polypeptide epitope based vaccine composition
KR20200096904A (en) * 2017-09-15 2020-08-14 오하이오 스테이트 이노베이션 파운데이션 Vaccines for the prevention of respiratory syncytial virus (RSV) infection and methods of making and using vaccines
CN111019910B (en) * 2019-11-04 2022-03-15 上海青赛生物科技有限公司 F genotype mumps virus attenuated strain, construction method and application thereof
CN111849927B (en) * 2020-06-28 2022-07-08 浙江大学 Method for efficiently producing recombinant nonsegmented negative-sense RNA virus and recombinant virus
CN116676275B (en) * 2023-03-17 2024-06-07 北京赛尔富森生物科技有限公司 A-genotype chimeric mumps virus strain and preparation method and application thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5786199A (en) * 1989-08-28 1998-07-28 The Mount Sinai School Of Medicine Of The City University Of New York Recombinant negative strand RNA virus expression systems and vaccines
US5869036A (en) * 1995-12-08 1999-02-09 St. Louis University Live attenuated vaccines based on CP45 HPIV-3 strain and method to ensure attenuation in such vaccine
BR9710363A (en) * 1996-07-15 2000-01-11 Us Gov Health & Human Serv "Isolated infectious recombinant respiratory syncytial virus, particulate, processes to stimulate an individual's immune system to induce protection against respiratory syncytial virus and to produce a particle of recombinant respiratory syncytial virus, vaccine to induce protection against recombinant respiratory syncytial virus. composition and collection of recombinant respiratory syncytial virus "

Also Published As

Publication number Publication date
JP4646410B2 (en) 2011-03-09
AU4231500A (en) 2000-11-14
MXPA01010392A (en) 2003-09-15
CN1347458A (en) 2002-05-01
BR0011159A (en) 2002-07-23
AU2005203596C1 (en) 2009-12-10
AU2005203596B8 (en) 2009-12-10
AU2005203596B2 (en) 2008-09-11
AU2005203596A1 (en) 2005-09-08
EP1171623A2 (en) 2002-01-16
KR20020008831A (en) 2002-01-31
JP2002541798A (en) 2002-12-10
KR100760328B1 (en) 2007-10-04
AU781238B2 (en) 2005-05-12
CA2369817A1 (en) 2000-10-19
WO2000061737A2 (en) 2000-10-19
WO2000061737A3 (en) 2001-08-23

Similar Documents

Publication Publication Date Title
IL145797A0 (en) Production of attenuated negative stranded rna virus vaccines from cloned nucleotide sequences
AU1824101A (en) Nucleotide sequences of moraxella catarrhalis genome
AU2001288257A1 (en) Improved methods of gene silencing using inverted repeat sequences
HUP0004115A2 (en) Novel nucleotide sequences coding for the pck gene
HK1047769A1 (en) Regulation of viral gene expression
GB2363795B (en) Process for nucleic acid purification using silicon carbide
PT1234024E (en) CONSTRUCTIONS OF ARTIFICIAL CHROMOSOMES CONTAINING NUCLEIC ACID SEQUENCES ABLE TO DIRECT THE FORMATION OF A RECOMBINANT RNA VIRUS
HUP0003651A3 (en) Novel nucleotide sequences coding for the pgi gene
IL145796A0 (en) Production of attenuated chimeric respiratory syncytial virus vaccines from cloned nucleotide sequences
AU2002339603A1 (en) Replicons derived from positive strand rna virus genomes useful for the production of heterologous proteins
HUP0302593A3 (en) Self-replicating rna molecule from hepatitis c virus
HUP0104450A3 (en) Nucleotide sequences for the tal gene
IL153388A0 (en) Manipulation of negative stranded rna viruses by rearrangement of their genes and uses thereof
EP1581614A4 (en) Nucleotide sequences for gene regulation and methods of use thereof
EP1581614A3 (en) Nucleotide sequences for gene regulation and methods of use thereof
GB0123401D0 (en) Methods of inducing gene expression
AU6795201A (en) Nucleic acid sequences and methods for the modification of plant gene expression
WO2001040521A3 (en) Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
EP1437408A4 (en) Novel antisense oligonucleotide derivatives against hepatitis c virus
IL152548A0 (en) Regulatory nucleic acid sequences of the abc1 gene
MXPA02001009A (en) Attenuated influenza virus useful as vaccine.
AU2002226307A1 (en) Artificial chromosomes comprising concatemers of expressible nucleotide sequences
AU2002212255A1 (en) Nucleotide sequences which code for the trub gene
HU0003279D0 (en) Process for preparation of metabolic products and nucleotide sequences encoding for the sod gene
AU2001293730A1 (en) Nucleotide sequences which code for the chra gene

Legal Events

Date Code Title Description
MM9K Patent not in force due to non-payment of renewal fees